These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10619489

  • 1. Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.
    Abdul-Wahab K, Corcoran D, Perachiotti A, Darbre PD.
    Cell Prolif; 1999 Oct; 32(5):271-87. PubMed ID: 10619489
    [Abstract] [Full Text] [Related]

  • 2. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM, Gierthy JF, Pentecost BT.
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [Abstract] [Full Text] [Related]

  • 3. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ, Harris WH, Wang DY, Darbre PD.
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [Abstract] [Full Text] [Related]

  • 4. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
    Cavaillès V, Gompel A, Portois MC, Thénot S, Mabon N, Vignon F.
    J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
    [Abstract] [Full Text] [Related]

  • 5. Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation.
    Corcoran D, Perachiotti A, Darbre PD.
    Cell Prolif; 1996 Sep; 29(9):479-93. PubMed ID: 8980655
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of insulin-like growth factor II in human breast cancer cells.
    Abdul-Wahab K, Perachiotti A, Corcoran D, Darbre PD.
    Biochem Soc Trans; 1996 Aug; 24(3):364S. PubMed ID: 8878908
    [No Abstract] [Full Text] [Related]

  • 7. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M, van den Berg HW, Lynch M.
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor receptor levels are regulated by cell density and by long term estrogen deprivation in MCF7 human breast cancer cells.
    Stephen RL, Shaw LE, Larsen C, Corcoran D, Darbre PD.
    J Biol Chem; 2001 Oct 26; 276(43):40080-6. PubMed ID: 11457860
    [Abstract] [Full Text] [Related]

  • 9. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
    Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H.
    Exp Cell Res; 2006 Nov 15; 312(19):3899-908. PubMed ID: 17014845
    [Abstract] [Full Text] [Related]

  • 10. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ.
    Mol Endocrinol; 1996 Mar 15; 10(3):286-97. PubMed ID: 8833657
    [Abstract] [Full Text] [Related]

  • 11. Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid.
    Stephen R, Darbre PD.
    Br J Cancer; 2000 Nov 15; 83(9):1183-91. PubMed ID: 11027432
    [Abstract] [Full Text] [Related]

  • 12. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC.
    Mol Endocrinol; 1994 Nov 15; 8(11):1474-83. PubMed ID: 7533260
    [Abstract] [Full Text] [Related]

  • 13. Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
    van den Berg HW, Claffie D, Boylan M, McKillen J, Lynch M, McKibben B.
    Br J Cancer; 1996 Feb 15; 73(4):477-81. PubMed ID: 8595162
    [Abstract] [Full Text] [Related]

  • 14. Identification of human estrogen-inducible transcripts that potentially mediate the apoptotic response in breast cancer.
    Szelei J, Soto AM, Geck P, Desronvil M, Prechtl NV, Weill BC, Sonnenschein C.
    J Steroid Biochem Mol Biol; 2000 Mar 15; 72(3-4):89-102. PubMed ID: 10775800
    [Abstract] [Full Text] [Related]

  • 15. Oestrogenic activity of isobutylparaben in vitro and in vivo.
    Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ.
    J Appl Toxicol; 2002 Mar 15; 22(4):219-26. PubMed ID: 12210538
    [Abstract] [Full Text] [Related]

  • 16. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells.
    Lee AV, Darbre P, King RJ.
    Mol Cell Endocrinol; 1994 Mar 15; 99(2):211-20. PubMed ID: 8206329
    [Abstract] [Full Text] [Related]

  • 17. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W.
    J Cell Physiol; 1994 Jun 15; 159(3):531-41. PubMed ID: 8188767
    [Abstract] [Full Text] [Related]

  • 18. Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression.
    Zhang L, Kim M, Choi YH, Goemans B, Yeung C, Hu Z, Zhan S, Seth P, Helman LJ.
    J Biol Chem; 1999 May 07; 274(19):13118-26. PubMed ID: 10224065
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH.
    Mol Endocrinol; 1989 Nov 07; 3(11):1701-9. PubMed ID: 2558302
    [Abstract] [Full Text] [Related]

  • 20. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA, Surmacz E.
    Exp Cell Res; 1997 Feb 25; 231(1):149-62. PubMed ID: 9056422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.